Brainsway (BWAY) Other financing activities (2018 - 2024)

Brainsway's (BWAY) quarterly Other financing activities came in at -$2000.0 in Q4 2024, down 100.01% on a QoQ basis from $17.0 million in Q4 2020.

Brainsway (BWAY) Other financing activities (2018 - 2024) Analysis & Trends

Brainsway (BWAY) has 4 years of Other financing activities data on file, last reported at -$2000.0 in Q4 2024.

Quarterly Other financing activities changed N/A year-over-year to -$2000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $17.1 million (changed N/A YoY) and the FY2024 annual result came in at $17000.0, changed N/A from the prior year.
Other financing activities eased to -$2000.0 in Q4 2024, from $17.0 million in the prior quarter.
In the past five years, Other financing activities ranged from a high of $17.0 million in Q4 2020 to a low of -$111000.0 in Q2 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn
10	Brainsway	570.08 Mn	506.91 Mn	12.77 Mn

Download Data